Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study

  • June Hwa Bae
  • , Yoo Jin Lee
  • , Jung Bin Park
  • , Ji Eun Baek
  • , Seung Wook Hong
  • , Sang Hyoung Park
  • , Dong Hoon Yang
  • , Byong Duk Ye
  • , Jeong Sik Byeon
  • , Seung Jae Myung
  • , Suk Kyun Yang
  • , Kyeong Ok Kim
  • , Byung Ik Jang
  • , Eun Soo Kim
  • , Hyeong Ho Jo
  • , Eun Young Kim
  • , Sung Wook Hwang

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science